Evidence map›Paper›PMID 35681733›Full record

ArticleCancers2022

Amelanotic Uveal Melanomas Evaluated by Indirect Ophthalmoscopy Reveal Better Long-Term Prognosis Than Pigmented Primary Tumours-A Single Centre Experience.

Anna Markiewicz, Piotr Donizy, Monika Nowak, Mateusz Krzyziński, Martyna Elas, Przemysław M Płonka, Jolanta Orłowska-Heitzmann, Przemysław Biecek, Mai P Hoang, Bożena Romanowska-Dixon

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Anna MarkiewiczDepartment of Ophthalmology and Ocular Oncology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.ORCID 0000-0003-0943-6575
Piotr DonizyDepartment of Clinical and Experimental Pathology, Division of Clinical Pathology, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-8729-6216
Monika NowakDepartment of Ophthalmology and Ocular Oncology, University Hospital, 31-501 Krakow, Poland.
Mateusz KrzyzińskiFaculty of Mathematics and Information Science, Warsaw University of Technology, 00-628 Warsaw, Poland.
Martyna ElasDepartment of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0001-6296-2844
Przemysław M PłonkaDepartment of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0002-0261-3439
Jolanta Orłowska-HeitzmannDepartment of Pathomorphology, University Hospital in Krakow, 30-688 Krakow, Poland.
Przemysław BiecekFaculty of Mathematics and Information Science, Warsaw University of Technology, 00-628 Warsaw, Poland.
Mai P HoangDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-1406-7981
Bożena Romanowska-DixonDepartment of Ophthalmology and Ocular Oncology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
Jagiellonian University · PLWarsaw University of Technology · PLHarvard University · USKrakow Cardiovascular Research Institute · PLWroclaw Medical University · PL

Funding

EU grant "UMCure2020: New Therapies for Uveal Melanoma" 667787Ministry of Education and Science in the "Regional Initiative of Excellence" programme for the years 2019-2022 016/RID/2018/19The Polish National Science Centre under Opus Grant 2017/27/B/ST6/0130
6 · The paper itself

Abstract

(1) Background: There is a constant search for new prognostic factors that would allow us to accurately determine the prognosis, select the type of treatment, and monitor the patient diagnosed with uveal melanoma in a minimally invasive and easily accessible way. Therefore, we decided to evaluate the prognostic role of its pigmentation in a clinical assessment. (2) Methods: The pigmentation of 154 uveal melanomas was assessed by indirect ophthalmoscopy. Two groups of tumours were identified: amelanotic and pigmented. The statistical relationships between these two groups and clinical, pathological parameters and the long-term survival rate were analyzed. (3) Results: There were 16.9% amelanotic tumours among all and they occurred in younger patients (p = 0.022). In pigmented melanomas, unfavourable prognostic features such as: epithelioid cells (p = 0.0013), extrascleral extension (p = 0.027), macronucleoli (p = 0.0065), and the absence of BAP1 expression (p = 0.029) were statistically more frequently observed. Kaplan−Meier analysis demonstrated significantly better overall (p = 0.017) and disease-free (p < 0.001) survival rates for patients with amelanotic tumours. However, this relationship was statistically significant for lower stage tumours (AJCC stage II), and was not present in larger and more advanced stages (AJCC stage III). (4) Conclusions: The results obtained suggested that the presence of pigmentation in uveal melanoma by indirect ophthalmoscopy was associated with a worse prognosis, compared to amelanotic lesions. These findings could be useful in the choice of therapeutic and follow-up options in the future.

Indexed as

amelanoticamelanotic melanomamelaninmelanomamelanoma pigmentationocular melanomapigmentationprognosisuveal melanoma

Identifiers

PMID35681733
PMCPMC9179456
OpenAlexW4281748820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.